JP2025507279A5 - - Google Patents

Info

Publication number
JP2025507279A5
JP2025507279A5 JP2024545792A JP2024545792A JP2025507279A5 JP 2025507279 A5 JP2025507279 A5 JP 2025507279A5 JP 2024545792 A JP2024545792 A JP 2024545792A JP 2024545792 A JP2024545792 A JP 2024545792A JP 2025507279 A5 JP2025507279 A5 JP 2025507279A5
Authority
JP
Japan
Prior art keywords
fus
antisense oligonucleotide
disease
pharmaceutical composition
oligonucleotide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024545792A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507279A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2023/050067 external-priority patent/WO2023147630A1/en
Publication of JP2025507279A publication Critical patent/JP2025507279A/ja
Publication of JP2025507279A5 publication Critical patent/JP2025507279A5/ja
Pending legal-status Critical Current

Links

JP2024545792A 2022-02-02 2023-02-02 病原性fusバリアントに関連する疾患を処置するための組成物および方法 Pending JP2025507279A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2022900200A AU2022900200A0 (en) 2022-02-02 Compositions and Methods for Treating Diseases Associated with Pathogenic FUS Variants
AU2022900200 2022-02-02
PCT/AU2023/050067 WO2023147630A1 (en) 2022-02-02 2023-02-02 Compositions and methods for treating diseases associated with pathogenic fus variants

Publications (2)

Publication Number Publication Date
JP2025507279A JP2025507279A (ja) 2025-03-18
JP2025507279A5 true JP2025507279A5 (https=) 2025-12-17

Family

ID=87553059

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024545792A Pending JP2025507279A (ja) 2022-02-02 2023-02-02 病原性fusバリアントに関連する疾患を処置するための組成物および方法

Country Status (8)

Country Link
US (1) US20250382612A1 (https=)
EP (1) EP4473111A1 (https=)
JP (1) JP2025507279A (https=)
KR (1) KR20240141197A (https=)
CN (1) CN118871584A (https=)
AU (1) AU2023215555A1 (https=)
CA (1) CA3243618A1 (https=)
WO (1) WO2023147630A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244851A1 (en) * 2004-01-13 2005-11-03 Affymetrix, Inc. Methods of analysis of alternative splicing in human
US20140349938A1 (en) * 2011-06-03 2014-11-27 President And Fellows Of Harvard College Methods of diagnosing and treating amyotrophic lateral sclerosis
HRP20250468T1 (hr) * 2019-05-28 2025-07-18 Ionis Pharmaceuticals. Inc. SPOJEVI I METODE ZA SMANJENJE POKAZATELJA FUS-a

Similar Documents

Publication Publication Date Title
JP6511124B2 (ja) 真核細胞におけるエキソンスキッピングの誘導
Sobczak et al. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy
JP2009537129A (ja) エキソンスキッピングを誘発する為の手段及び方法
EP4404941A1 (en) Therapeutics for haploinsufficiency conditions
JP2025507279A5 (https=)
AU2012200761B2 (en) Induction of exon skipping in eukaryotic cells
US20250354142A1 (en) Functional nucleic acid molecule
CN112779252B (zh) 靶向SMN2启动子区MeCP2结合的关键甲基化区域的反义寡核苷酸
HK1188250B (en) Induction of exon skipping in eukaryotic cells
HK1188251A (en) Induction of exon skipping in eukaryotic cells
HK1188251B (en) Induction of exon skipping in eukaryotic cells
HK1184818B (en) Induction of exon skipping in eukaryotic cells
HK1188249B (en) Induction of exon skipping in eukaryotic cells
HK1154619B (en) Induction of exon skipping in eukaryotic cells
HK1184819B (en) Induction of exon skipping in eukaryotic cells
HK1184821B (en) Induction of exon skipping in eukaryotic cells
HK1203554B (en) Induction of exon skipping in eukaryotic cells
HK1216906B (en) Induction of exon skipping in eukaryotic cells
HK1184820B (en) Induction of exon skipping in eukaryotic cells